Centurion Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$531K Sell
4,132
-460
-10% -$53.8K 0.13% 152
2026
Q1
$552K Sell
4,592
-6
-0.1% -$693 0.12% 153
2025
Q4
$484K Buy
4,598
+371
+9% +$34.8K 0.11% 166
2025
Q3
$355K Buy
4,227
+1,134
+37% +$93.4K 0.08% 198
2025
Q2
$245K Sell
3,093
-292
-9% -$23.2K 0.07% 200
2025
Q1
$337K Hold
3,385
0.11% 139
2024
Q4
$337K Sell
3,385
-630
-16% -$65K 0.11% 139
2024
Q3
$456K Buy
+4,015
New +$477K 0.15% 110
2024
Q1
$478K Sell
3,623
-164
-4% -$20.2K 0.19% 90
2023
Q4
$413K Buy
3,787
+58
+2% +$6.02K 0.18% 95
2023
Q3
$384K Buy
3,729
+28
+0.8% +$3.02K 0.19% 90
2023
Q2
$427K Hold
3,701
0.21% 87
2023
Q1
$394K Sell
3,701
-54
-1% -$5.83K 0.2% 91
2022
Q4
$417K Buy
+3,755
New +$384K 0.24% 89

Other funds holding MRK

Centurion Wealth Management's MRK Position: Q2 2026 in Review

Centurion Wealth Management reduced its Merck (MRK) stake by 10% in Q2 2026, selling an estimated $53.8K and leaving 4,132 shares worth $531K. The position accounts for 0.13% of the portfolio, ranked #152.

Centurion Wealth Management first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $552K in Q1 2026. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Centurion Wealth Management held 4,132 shares of Merck worth $531K as of Q2 2026.
  • Centurion Wealth Management sold 460 Merck shares in Q2 2026, an estimated $53.8K.
  • Merck made up 0.13% of Centurion Wealth Management's portfolio in Q2 2026, its #152 holding.
  • Centurion Wealth Management first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Centurion Wealth Management's Merck position peaked at $552K in Q1 2026.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.